Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer
Mavroudis, D., Papakotoulas, P., Ardavanis, A., Syrigos, K., Kakolyris, S., Ziras, N., Kouroussis, C., Malamos, N., Polyzos, A., Christophyllakis, C., Kentepozidis, N., Georgoulias, V.
Published in Annals of oncology (01.01.2010)
Published in Annals of oncology (01.01.2010)
Get full text
Journal Article
A multicenter phase I–II study of docetaxel plus epirubicin plus bevacizumab as first-line treatment in women with HER2-negative metastatic breast cancer
Tryfonidis, K, Boukovinas, I, Xenidis, N, Christophyllakis, C, Papakotoulas, P, Politaki, E, Malamos, N, Polyzos, A, Kakolyris, S, Georgoulias, V, Mavroudis, D
Published in Breast (Edinburgh) (01.12.2013)
Published in Breast (Edinburgh) (01.12.2013)
Get full text
Journal Article
Gemcitabine combined with carboplatin in the first-line of treatment of elderly patients with non-small-cell lung cancer: A multicenter phase II trial by the Hellenic Oncology Research Group (HORG)
Karampeazis, A, Vamvakas, L, Kentepozidis, N, Agelaki, S, Kotsakis, A, Polyzos, A, Milaki, G, Christophyllakis, C, Matikas, A, Kouroussis, C, Mavroudis, D, Georgoulias, V
Published in Journal of geriatric oncology (01.10.2014)
Published in Journal of geriatric oncology (01.10.2014)
Get full text
Journal Article
Final results of weekly paclitaxel and carboplatin plus bevacizumab as first-line treatment of triple-negative breast cancer. A multicenter phase I-II trial by the Hellenic Oncology Research Group
Nikolaou, M., Saloustros, E., Polyzos, A., Christophyllakis, C., Kentepozidis, N., Vamvakas, L., Kalbakis, K., Agelaki, S., Georgoulias, V., Mavroudis, D.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Randomised phase-II trial of CAPIRI (capecitabine, irinotecan) plus bevacizumab vs FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) plus bevacizumab as first-line treatment of patients with unresectable/metastatic colorectal cancer (mCRC)
Souglakos, J, Ziras, N, Kakolyris, S, Boukovinas, I, Kentepozidis, N, Makrantonakis, P, Xynogalos, S, Christophyllakis, Ch, Kouroussis, Ch, Vamvakas, L, Georgoulias, V, Polyzos, A
Published in British journal of cancer (31.01.2012)
Published in British journal of cancer (31.01.2012)
Get full text
Journal Article
A phase I/II study of docetaxel/epirubicin/bevacizumab (DEB) as first-line therapy for metastatic, HER2-negative breast cancer (MBC)
Mavroudis, D., Boukovinas, I., Christophyllakis, C., Xenidis, N., Papakotoulas, P., Malamos, N. A., Kakolyris, S., Polyzos, A., Georgoulias, V.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Pemetrexed (MTA) compared with erlotinib (ERL) in pretreated patients with advanced non-small cell lung cancer (NSCLC): Results of a randomized phase III Hellenic Oncology Research Group trial
Vamvakas, L., Agelaki, S., Kentepozidis, N. K., Karampeazis, A., Pallis, A. G., Christophyllakis, C., Kotsakis, A. P., Boukovinas, I., Mavroudis, D., Georgoulias, V.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Docetaxel (D) plus gemcitabine (G) compared with G in elderly patients with advanced non-small cell lung cancer (NSCLC): Preliminary results of a randomized phase III Hellenic Oncology Research Group trial
Karampeazis, A., Vamvakas, L., Pallis, A. G., Christophyllakis, C., Kentepozidis, N. K., Chandrinos, V., Polyzos, A., Athanasiadis, A., Milaki, G., Georgoulias, V.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A randomized phase II trial of irinotecan plus oxaliplatin versus oxaliplatin, fluorouracil (5 FU), leukovorin (LV) as first-line treatment in advanced gastric cancer
Boukovinas, I., Androulakis, N., Polyzos, A., Vardakis, N., Amarantidis, K., Bozionelou, V., Kouroussis, C., Giassas, S., Christophyllakis, C., Mavroudis, D.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
Randomized phase III trial comparing the sequential administration of docetaxel followed by epirubicin plus cyclophosphamide versus FE 75 C as adjuvant chemotherapy in axillary lymph node-positive breast cancer
Mavroudis, D., Malamos, N., Papakotoulas, P., Adamou, A., Christophyllakis, C., Ziras, N., Syrigos, K., Kakolyris, S., Kouroussis, C., Georgoulias, V.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Phase I study of gemcitabine (GEM) and premetrexed (ptx) in the treatment of advanced solid tumors
Kalykaki, A., Agelaki, S., Kalbakis, K., Kotsakis, A., Kentepozidis, N., Christophyllakis, C., Giassas, S., Vamvakas, L., Vardakis, N., Mavroudis, D.
Published in Journal of clinical oncology (20.06.2006)
Published in Journal of clinical oncology (20.06.2006)
Get full text
Journal Article